Results 201 to 210 of about 48,370 (295)

Interactive Effects of IL-1β and TGF-β on Urokinase-Type Plasminogen Activator and α-Smooth Muscle Actin Expression by Corneal Fibroblasts. [PDF]

Invest Ophthalmol Vis Sci
Sugioka K, Nishida T, Yunoki M, Mukai N, Murakami J, Kusaka S.   +5 more
europepmc   +1 more source

Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression and [⁶⁴Cu]Cu-DOTA-AE105 uPAR-PET/CT in Patient-Derived Xenograft Models of Oral Squamous Cell Carcinoma. [PDF]

Mol Imaging Biol, 2023
Lawaetz M, Binderup T, Christensen A, Juhl K, Lelkaitis G, Lykke E, Knudsen L, von Buchwald C, Kjaer A.   +8 more
europepmc   +1 more source

Kunitz-type Protease Inhibitor Bikunin Disrupts Phorbol Ester-induced Oligomerization of CD44 Variant Isoforms Containing Epitope v9 and Subsequently Suppresses Expression of Urokinase-type Plasminogen Activator in Human Chondrosarcoma Cells [PDF]

, 2002
Mika Suzuki, Hiroshi Kobayashi, Michio Fujie, Takashi Nishida, Masaharu Takigawa, Naohiro Kanayama, Toshihiko Terao   +6 more
openalex   +1 more source

Remodeling the sarcoma microenvironment by simultaneous targeting of urokinase-type plasminogen activator receptors and epidermal growth factor receptors to promote antitumor activity. [PDF]

J Pharmacol Exp Ther
Schulte AJ, Lewellen M, Durose W, Nolan E, Taghizadeh L, Todhunter D, Bush C, Lang HP, Brown ME, DePauw TA, Makielski KM, Kim JH, Burt LE, Overn P, Forster CL, Seelig DM, O'Sullivan MG, Weigel BJ, Murugan P, Cutter GR, Lund TC, Vallera DA, Modiano JF.   +22 more
europepmc   +1 more source

Author Correction: Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients. [PDF]

Sci Rep, 2023
Risør LM, Binderup T, Fosbøl MØ, Andersen KF, Loft A, Friborg J, Kjaer A.   +6 more
europepmc   +1 more source

Different kinetics of urokinase-type plasminogen activator and plasminogen activator inhibitor production on cancer cell growth

, 1994
Kousuke Marutsuka, Yasuo Asada, A Sumiyoshi   +2 more
openalex   +1 more source

DEMONSTRATION OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN ACTIVATOR (scu-PA) ON HUMAN PLATELET MEMBRANES [PDF]

, 1987
S Park, Laurence A. Harker, E G Levin
openalex   +1 more source

Urokinase-type plasminogen activator deficiency enhances CD8⁺ T cell infiltration and anti-PD-1 therapy efficacy in prostate cancer. [PDF]

Front Immunol
Li X, Zhang X, Fu X, Wu H, Ye X, Huang X, Cui Y, Qian CN, Lu Y, Zhang J.   +9 more
europepmc   +1 more source

A Novel Marine Pyran-Isoindolone Compound Enhances Fibrin Lysis Mediated by Single-Chain Urokinase-Type Plasminogen Activator. [PDF]

Mar Drugs, 2022
Gao C, Tang S, Zhang H, Zhang H, Zhang T, Bao B, Zhu Y, Wu W.   +7 more
europepmc   +1 more source

Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects [PDF]

, 2008
Manfred Schmitt, Karin Mengele, Apostolos Gkazepis, Rudolf Napieralski, Viktor Magdolen, Ute Reuning, Nadia Harbeck   +6 more
openalex   +1 more source